Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx Subclones, 1968 to 2012

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6886-6895

  Olesen, Bente ^a   Frimodt Møller, Jakob ^a,b   Leihof, Rikke Fleron ^b   Struve, Carsten ^b   Johnston, Brian ^c   Hansen, Dennis S ^a   Scheutz, Flemming ^b   Krogfelt, Karen A ^b   Kuskowski, Michael A ^c   Clabots, Connie ^c   Johnson, James R ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; APRAMYCIN; BACTERIAL ANTIGEN; CEFOTAXIME; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; FLORFENICOL; GENTAMICIN; MEROPENEM; NALIDIXIC ACID; NEOMYCIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VEROTOXIN; BACTERIAL POLYSACCHARIDE; BETA LACTAMASE; SHIGA TOXIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOFILM; BROTH DILUTION; CLONE; ESCHERICHIA COLI; ESCHERICHIA COLI K 12; ESCHERICHIA COLI SEQUENCE TYPE 131; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; GENOTYPE; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; BIOSYNTHESIS; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY;

ANTIGENS, BACTERIAL; BETA-LACTAMASES; BIOFILMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TESTS; POLYSACCHARIDES, BACTERIAL; SEROGROUP; SHIGA TOXINS; VIRULENCE FACTORS;

EID: 84908424409     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03679-14     Document Type: Article

References (36)

1. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14. http://dx.doi.org/10.1093/jac/dkq415.
2. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294. http://dx.doi.org/10.1086/653932.
3. Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A. 2013. Predictors and molecular epidemiology of community-onset extended-spectrum beta-lactamase-producing Escherichia coli infection in a midwestern community. Infect. Control Hosp. Epidemiol. 34:947-953. http://dx.doi.org/10.1086/671725.
4. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4:e00377-13. http://dx.doi.org/10.1128/mBio.00377-13.
5. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott D, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye A, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV. 3 January 2013. Abrupt emergence of a single dominant multi-drug-resistant strain of Escherichia coli. J. Infect. Dis http://dx.doi.org/10.1093/infdis/jis933.
6. Nicolas-Chanoine MH, Bertrand X, Madec JY. 2014. Escherichia coli ST131, an intriguing clonal group. Clin. Microbiol. Rev. 27:543-574. http://dx.doi.org/10.1128/CMR.00125-13.
7. Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob. Agents Chemother. 58:4997-5004. http://dx.doi.org/10.1128/AAC.02824-14.
8. Olesen B, Hansen DS, Nilsson F, Frimodt-Møller J, Leihof RF, Struve C, Scheutz F, Johnston B, Krogfelt KA, Johnson JR. 2013. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J. Clin. Microbiol. 51:1779-1785. http://dx.doi.org/10.1128/JCM.00346-13.
9. Mora A, Dahbi G, Lopez C, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso MP, Denamur E, Blanco J. 2014. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One 9:e87025. http://dx.doi.org/10.1371/journal.pone.0087025.
10. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. 2013. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin. Infect. Dis. 57:1256-1265. http://dx.doi.org/10.1093/cid/cit503.
11. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr. Infect. Dis. J. 32:543-548. http://dx.doi.org/10.1097/INF.0b013e31828ba3f1.
12. Olesen B, Scheutz F, Andersen RL, Menard M, Boisen N, Johnston B, Hansen DS, Krogfelt KA, Nataro JP, Johnson JR. 2012. Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection. J. Clin. Microbiol. 50:3703-3711. http://dx.doi.org/10.1128/JCM.01909-12.
13. Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, Krogfelt KA. 2013. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect. Immun. 81:1164-1171. http://dx.doi.org/10.1128/IAI.01376-12.
14. Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, Woodford N. 2010. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases. Int. J. Antimicrob. Agents 36:355-358. http://dx.doi.org/10.1016/j.ijantimicag.2010.06.007.
15. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739. http://dx.doi.org/10.1128/AAC.00297-09.
16. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A, ESBL Norwegian Study Group. 2009. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 117:526-536. http://dx.doi.org/10.1111/j.1600-0463.2009.02465.x.
17. Ørskov F, Ørskov I. 1984. Serotyping of Escherichia coli, p 43-112. In Bergan T (ed), Methods in microbiology, vol. 14. Academic Press, London, United Kingdom.
18. Konowalchuk J, Speirs JI, Stavric S. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-779.
19. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370. http://dx.doi.org/10.1128/AAC.05824-11.
20. Johnson JR, Owens K, Manges AR, Riley LW. 2004. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J. Clin. Microbiol. 42:2618-2622. http://dx.doi.org/10.1128/JCM.42.6.2618-2622.2004.
21. Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. 2006. Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 8:1702-1713. http://dx.doi.org/10.1016/j.micinf.2006.02.007.
22. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. http://dx.doi.org/10.1086/315217.
23. Johnson JR, Stell AL, Scheutz F, O'Bryan TT, Russo TA, Carlino UB, Fasching C, Kavle J, Van Dijk L, Gaastra W. 2000. Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect. Immun. 68:1587-1599. http://dx.doi.org/10.1128/IAI.68.3.1587-1599.2000.
24. Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA, Smith KE. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168. http://dx.doi.org/10.1128/AAC.47.7.2161-2168.2003.
25. Johnson JR, O'Bryan TT. 2004. Detection of the Escherichia coli group 2 polysaccharide capsule synthesis gene kpsM by a rapid and specific PCR-based assay. J. Clin. Microbiol. 42:1773-1776. http://dx.doi.org/10.1128/JCM.42.4.1773-1776.2004.
26. Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, Kotloff KL, Levine MM, Sow S, Tamboura B, Toure A, Malle D, Panchalingam S, Krogfelt KA, Nataro JP. 2012. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J. Infect. Dis. 205:431-444. http://dx.doi.org/10.1093/infdis/jir757.
27. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67. http://dx.doi.org/10.1089/fpd.2006.3.59.
28. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
29. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA, MASTER Investigators. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg. Infect. Dis. 18:598-607. http://dx.doi.org/10.3201/eid1804.111627.
30. Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, Justesen US, Frimodt-Møller N, DANRES Study Group. 2012. Extended-spectrum beta-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, beta-lactamase distribution, phylogroups, and co-resistance. Scand. J. Infect. Dis. 44:174-181. http://dx.doi.org/10.3109/00365548.2011.632642.
31. Cerquetti M, Giufre M, Garcia-Fernandez A, Accogli M, Fortini D, Luzzi I, Carattoli A. 2010. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin. Microbiol. Infect. 16:1555-1558. http://dx.doi.org/10.1111/j.1469-0691.2010.03162.x.
32. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Bano J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. 31 March 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl Acad. Sci. U. S. A. http://dx.doi.org/10.1073/pnas.1322678111.
33. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR. 2013. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H 30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob. Agents Chemother. 57:6385-6388. http://dx.doi.org/10.1128/AAC.01604-13.
34. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J, Spanish Group for Nosocomial Infections (GEIH). 2013. Four main virotypes among extended-spectrum-beta-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 51:3358-3367. http://dx.doi.org/10.1128/JCM.01555-13.
35. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin. Microbiol. Infect. 19:E173-E180. http://dx.doi.org/10.1111/1469-0691.12123.
36. Korhonen TK, Valtonen MV, Parkkinen J, Väisänen-Rhen V, Finne J, Orskov F, Orskov I, Svenson SB, Mäkelä PH. 1985. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect. Immun. 48:486-491.